1-20 of 128 Search Results for

patent

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
×Close Modal
Sort by
Journal Article
Journal of Health Politics, Policy and Law (1 August 2013) 38 (4): 735–755.
Published: 01 August 2013
...Bhaven N. Sampat; Tahir Amin The 1995 Trade Related Intellectual Property Rights (TRIPS) agreement required developing countries to grant product patents in pharmaceuticals. Developing countries have since explored various measures to ameliorate potential negative effects of the new laws on public...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2016) 41 (3): 423–450.
Published: 01 June 2016
... analysis health policy pharmaceutical patents In October 2015, the US government launched the Trans-Pacific Partnership, a trade agreement comprising twelve countries of the Pacific Rim, such as Chile and Peru, which among other economic liberalizations, enforce and expand intellectual property...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2017) 42 (3): 485–512.
Published: 01 June 2017
...Cassandra M. Sweet Abstract When patents expire, are equivalent generic alternatives available to citizens? This article contributes to current discussion on access to medicine in the aftermath of the World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2009) 34 (6): 979–1010.
Published: 01 December 2009
...Sandra Adamini; Hans Maarse; Esther Versluis; Donald W. Light After lengthening the duration of patents to twenty years in 1984, the pharmaceutical industry has turned to data exclusivity as a major vehicle for extending market protection, even after patents expire. Such protections give companies...
Journal Article
Journal of Health Politics, Policy and Law (1 April 2016) 41 (2): 157–179.
Published: 01 April 2016
...Denis G. Arnold; Jennifer L. Troyer Abstract The pharmaceutical industry has been criticized for developing and aggressively marketing drugs that do not provide significant health benefits relative to existing drugs but retain the benefits of patent protection. Critics argue that drug marketing...
Journal Article
Journal of Health Politics, Policy and Law (1 June 1994) 19 (3): 583–595.
Published: 01 June 1994
... race in admitting patients. This practice is patently objectionable; it also is costly to hospitals, thus to society, since hospitals bear the direct costs of delayed discharges and hospitals do not keep costs to themselves. While research is needed to determine whether the North Carolina findings are...
Image
Published: 01 October 2019
2015, both Viagra and Cialis started to prepare for the end of their patents with reduced advertising budgets. Figure 1 Direct-to-consumer media spending for erectile dysfunction (ED) category and Viagra and Cialis brands (in US$ millions): 2010–17. More
Journal Article
Journal of Health Politics, Policy and Law (1 April 2010) 35 (2): 303–304.
Published: 01 April 2010
...: Belknap Press of Harvard University Press, 2007. 162 pp. $12.95 paper. State Agency and the Patenting of Life in International Law: Merchants and Mis- sionaries in a Global Society. Bita Amani. Burlington, VT: Ashgate Publishing, 2009. 375 pp. $134.95 cloth. Taming the Beloved Beast: How Medical...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2014) 39 (3): 691–705.
Published: 01 June 2014
...-patent medicines. Our recommendations come from examining international evidence such as policy reports and peer-reviewed articles as well as the policy and political environment in Russia through international and local media coverage, local meetings, and from our experience with pharmaceutical...
Journal Article
Journal of Health Politics, Policy and Law (1 August 2013) 38 (4): 629–643.
Published: 01 August 2013
... suited to under- standing the dynamics of implementation of laws. Quantitative approaches are also possible, however, as demonstrated by the article on public health safeguards in Indian patent law by the economist Bhaven Sampat and the attorney Tahir Amin. In recent years, public health law scholars...
Journal Article
Journal of Health Politics, Policy and Law (1 August 2013) 38 (4): 879–885.
Published: 01 August 2013
... practicing solicitor in the Senior Courts of England and Wales for more than ten years, and adviser to various organizations including the World Health Organization, UNITAID, and GAVI Alliance. He has written extensively on pharmaceutical patenting and published articles in Health Affairs, Science, and...
Journal Article
Journal of Health Politics, Policy and Law (1 October 2011) 36 (5): 905–908.
Published: 01 October 2011
... affiliations with Columbia Law School and School of International and Public Affairs. An economist by training, Sampat is centrally interested in issues at the intersection of health policy and innovation policy. His current work examines generic challenges to pharmaceutical patents in the United States...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2015) 40 (6): 1225–1226.
Published: 01 December 2015
..., and Deliberative Governance: Patents as Discourse on Life . Katerina Sideri. Burlington, VT: Ashgate. 2014. 196 pp. $61.00 cloth. Handbook for Health Care Ethics Committees . Linda Farber Post and Jeffrey Blustein. 2nd ed. Baltimore: Johns Hopkins University Press. 2015. 352 pp. $49.95 paper...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2013) 38 (3): 573–597.
Published: 01 June 2013
...) . Cambridge, MA : National Bureau of Economic Research . Ching A. T. 2010 . “A Dynamic Oligopoly Structural Model for the Prescription Drug Market after Patent Expiration.” International Economic Review 51 , no. 4 : 1175 – 207 . Cohen M. R. Di Domizio G. Lee R. E. Jr...
Journal Article
Journal of Health Politics, Policy and Law (1 October 2007) 32 (5): 895–913.
Published: 01 October 2007
... expenses that benefit R&D, such as upgrades to entire corporate com- puter or software systems or legal expenses pertinent to R&D, patents, and new products (Light 2006a). Third, no mention was made by the authors of verifying the data or cleaning it in the usual ways done by researchers using open...
Journal Article
Journal of Health Politics, Policy and Law (1 February 2009) 34 (1): 145–148.
Published: 01 February 2009
.... Baltimore: Johns Hopkins University Press, 2007. 488 pp. $65.00 cloth; $29.95 paper. The Regulatory Challenge of Biotechnology: Human Genetics, Food, and Patents. Han Somsen, ed. Northampton, MA: Edward Elgar Publications, 2007. 296 pp. $130.00 cloth. Health Politics and Policy The Biopolitics of...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2016) 41 (3): 311–313.
Published: 01 June 2016
... crises. Finally, Elize Massard da Fonseca and Francisco Inácio Bastos conduct a case study of patent regulation in Brazil to examine larger questions pertaining to policy making in middle-income countries. There is concern that middle-income countries are primarily susceptible to the influence of...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2013) 38 (6): 1205–1209.
Published: 01 December 2013
... Other Nations Can Tell Us about Next Steps in Reforming U.S. Health Care (David A. Rochefort and Kevin P. Donnelly), 3:611–14 Ruger, Theodore W. “Our Federalism” Moves Indoors, 2:283–89 Sampat, Bhaven N., and Tahir Amin. How Do Public Health Safeguards in Indian Patent Law Affect Pharmaceutical...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2014) 39 (6): 1289–1294.
Published: 01 December 2014
...., trials and patent issues), and telemedicine as major areas of health care where globalization, legal confusion, and scope for policy improvement are found. The last section, on “globalization, equity, and justice,” is a sort of summary discussion of broad ethical issues in the globalization of health...
Journal Article
Journal of Health Politics, Policy and Law (1 April 2011) 36 (2): 295–316.
Published: 01 April 2011
...). To address this apparent disparity, bills have been introduced in Congress to legalize commercial drug importation (also called parallel trade, which is legally permitted in the European Union), permitting wholesalers and other third parties to import on-­patent prescription drugs from...